GlassScriptPhysician profile
Daniel Ahmad
NPI 1386055622
$27,920.50
in general payments reported to CMS, 2019-2025
41 companies · $4,160 in 2025
The $4,160 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $5,317 · 2021: $3,863 · 2022: $5,824 · 2023: $5,188 · 2024: $3,412 · 2025: $4,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,133 · Travel and Lodging: $2,477 · Consulting Fee: $2,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,133.13 |
| Travel and Lodging | $2,477.43 |
| Consulting Fee | $2,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,581.60 | 2020-2024 | Optis, Mitraclip, Cardiomems |
| Edwards Lifesciences Corporation | $6,154.03 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $3,308.62 | 2021-2025 | Mamba, Avvigo Guidance System, Watchman Access System |
| Abiomed | $1,879.14 | 2019-2025 | Impella |
| Penumbra, INC. | $1,227.07 | 2020-2023 | Indigo System |
| Shockwave Medical, INC | $1,140.66 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $1,020.32 | 2020-2022 | |
| Medtronic, INC. | $849.71 | 2021-2022 | |
| Biotronik INC. | $753.18 | 2021-2024 | Orsiro Mission |
| Cardiovascular Systems INC. | $450.42 | 2021-2022 | |
| Acist Medical Systems, INC. | $412.81 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $337.41 | 2020-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $263.16 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $240.70 | 2023-2024 | Xarelto, Opsumit, Uptravi |
| Siemens Medical Solutions USA, INC. | $224.36 | 2023-2024 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $221.06 | 2024 | Peripheral Vascular |
| Chiesi USA, INC. | $211.88 | 2020-2025 | Kengreal |
| Heartflow, INC. | $198.29 | 2024-2025 | |
| Jenavalve Technology, INC. | $185.13 | 2021 | |
| Terumo Medical Corporation | $141.18 | 2022-2023 | Tr Band |
| W. L. Gore & Associates, INC. | $135.10 | 2022 | |
| Novartis Pharmaceuticals Corporation | $130.10 | 2020-2025 | |
| Cardiva Medical, INC. | $97.97 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| E.R. Squibb & Sons, L.L.C. | $89.33 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.06 | 2023-2024 | Jardiance |
| Philips North America LLC | $67.29 | 2022 | |
| Reflow Medical INC | $63.45 | 2024 | |
| Inari Medical, INC. | $57.11 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $49.98 | 2024 | Wegovy |
| Cvrx, INC. | $48.21 | 2024 | Barostim Neo System |
| Stryker Corporation | $45.90 | 2025 | |
| Amgen INC. | $40.10 | 2024-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $36.39 | 2023 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $34.85 | 2023-2024 | |
| Abbvie INC. | $24.69 | 2025 | |
| Trevena, INC. | $24.01 | 2022 | |
| Teleflex LLC | $23.94 | 2022 | |
| Pfizer INC. | $23.69 | 2020 | |
| Imperative Care, INC | $19.72 | 2025 | Symphony Catheter |
| Kestra Medical Technology Services, INC. | $15.48 | 2023 | Assure Wcd |
| Cordis US Corp. | $15.40 | 2023 | Saber |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.